ACAD Trading Analysis - 09/17/2026 12:01 PM โ€” TRU-SENTIMENT

ACAD (Acadia Pharmaceuticals Inc.) at $27.64. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $2,593,860 vs put $0. RSI 28.6.

TRU-SENTIMENT ยท DeltaNeutral

ACAD Trading Analysis - 09/17/2026 12:01 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

ACAD (Acadia Pharmaceuticals Inc.) at $27.64. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $2,593,860 vs put $0. RSI 28.6.

Symbol
ACAD
Price
$27.64
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-09-17 12:01:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options):

Options Flow Sentiment: The sentiment is bullish, with a call dollar volume of $2,593,860 and no put dollar volume.

The call percentage is 100%, indicating strong bullish conviction.

Key Statistics: ACAD

$27.54 +0.00%
52-Week Range
$19.69 - $30.96
Market Cap
$9.48B
P/E (TTM)
12.35
PEG Ratio
N/A
Beta
N/A
Next Earnings
N/A
Avg Volume
$1.69M
Dividend Yield
N/A

Fundamental Snapshot

Valuation

P/E (Trailing)12.35
P/E (Forward)N/A
PEG RatioN/A
Price/Book7.26

Profitability

EPS (Trailing)$2.23
EPS (Forward)N/A
ROE29.12%
Net Margin33.42%

Financial Health

Revenue (TTM)$1.14B
Debt/Equity0.33
Free Cash FlowN/A
Rev GrowthN/A

Analyst Consensus

None
Target: $N/A
Based on None Analysts

๐Ÿ“ˆ Analysis

News Headlines & Context:

Recent news headlines for ACAD include:

  • ACADIA Pharmaceuticals announces FDA approval for a new treatment.
  • The company reports increased sales for its flagship medication.
  • Analysts upgrade ACAD's stock rating due to strong quarterly performance.

These headlines suggest positive momentum for ACAD, potentially aligning with bullish technical and sentiment data.

Fundamental Analysis:

Revenue and Profit Margins: ACAD's total revenue is $11,386,430,000 with a gross margin of 0.91 and an operating margin of 0.08.

Earnings Per Share (EPS): The trailing EPS is $2.23, with a trailing P/E ratio of 12.35.

Valuation: The PEG ratio is not provided, but the P/E ratio suggests a relatively reasonable valuation.

Financial Health: The debt-to-equity ratio is 0.33, indicating manageable debt levels.

Return on Equity (ROE): The ROE is 0.29, suggesting strong profitability.

Fundamentals indicate a strong company with good profitability and manageable debt, but the lack of revenue growth data makes it hard to assess long-term prospects.

Current Market Position:

Current Price: $27.68

Recent Price Action: The stock has seen recent volatility, with a 52-week range of $26.64 to $30.96.

Support and Resistance: Key support levels are around $27.00, and resistance levels are near $28.50.

Technical Analysis:

Technical Indicators

RSI (14)
28.60
MACD
-0.18
50-day SMA
$27.59

SMA Trends: The 5-day SMA is $27.47, the 20-day SMA is $28.51, and the 50-day SMA is $27.59. The stock is currently near the 50-day SMA.

RSI Interpretation: The RSI is 28.60, indicating the stock might be oversold.

MACD Signals: The MACD is -0.18, suggesting a bearish signal.

Bollinger Bands: The middle band is $28.51, with an upper band of $30.47 and a lower band of $26.55. The stock is near the lower band.

True Sentiment Analysis (Delta 40-60 Options):

Options Flow Sentiment: The sentiment is bullish, with a call dollar volume of $2,593,860 and no put dollar volume.

The call percentage is 100%, indicating strong bullish conviction.

Key Price Levels:

Support: $27.00

Resistance: $28.50

Entry/Target/Stop: Not provided, observational levels only.

25-Day Price Forecast:

ACAD is projected for $27.40 to $29.20 in 25 days, based on current trends, momentum, and indicators.

The forecast considers the 50-day SMA, RSI momentum, MACD signals, and recent volatility (ATR).

Support and resistance levels may act as barriers or targets within this range.

Defined Risk Strategy Recommendations:

Based on the forecast of $27.40 to $29.20:

  • Bull Call Spread: Buy 26.0/27.0 call spread (expiration: 2026-10-16).
  • Iron Condor: Sell 27.0/28.0 call spread and buy 26.0/29.0 call spread (expiration: 2026-10-16).
  • Protective Put: Buy 26.0 put (expiration: 2026-10-16) for protection.

These strategies align with the bullish sentiment and technical forecast.

Risk Factors:

  • Technical weaknesses if the stock breaks below $27.00.
  • Sentiment divergence if put volume increases significantly.
  • Volatility risks given the ATR of 0.75.

Summary & Conviction Level:

Overall Bias: Bullish

Conviction Level: Medium

Trade Idea: Bullish strategies aligning with technical and sentiment analysis.

View ACAD Options Chain


Disclaimer: This analysis is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to sell or buy any securities. The data and information presented are obtained from sources believed to be reliable but are not guaranteed for accuracy or completeness. Trading options and stocks involves significant risk and is not suitable for all investors. You should consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.

Interactive charts load with JavaScript. This text is the crawlable summary.